Will gene–environment interactions explain differential antidepressant response?
References
- 1 Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry163(1),28–40 (2006).
- 2 Steimer W, Muller B, Leucht S, Kissling W. Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy. Clin. Chim. Acta308(1–2),33–41 (2001).
- 3 Franchini L, Serretti A, Gasperini M, Smeraldi E. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J. Psychiatr. Res.32(5),255–259 (1998).
- 4 Keers R, Aitchison KJ. Pharmacogenetics of antidepressant response. Exp. Rev. Neurother.11(1),101–125 (2011).
- 5 Zou YF, Wang F, Feng XL et al. Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders. Neurosci. Lett.484(1),56–61 (2011).
- 6 Taylor MJ, Sen S, Bhagwagar Z. Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol. Psychiatry68(6),536–543 (2010).
- 7 Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J. Affect. Disord.18(4),289–299 (1990).
- 8 Keers R, Uher R, Gupta B et al. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. J. Affect. Disord.127(1–3),337–342 (2010).
- 9 Horacek J, Rozehnalova E, Rosslerova H, Dvorak A. The influence of stressful life events on development of depression and treatment response in the population of patients in higher age. Ceska Slovenska Psychiatr.106(5),311–317 (2011).
- 10 Monroe SM, Kupfer DJ, Frank E. Life stress and treatment course of recurrent depression: 1. Response during index episode. J. Consult. Clin. Psychol.60(5),718–724 (1992).
- 11 Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. Do stressful life events predict medical treatment outcome in first episode of depression? Soc. Psychiatry Psychiatry Epidemiol.44(9),752–760 (2009).
- 12 Rutter M, Thapar A, Pickles A. Gene–environment interactions: biologically valid pathway or artifact? Arch. Gen. Psychiatry66(12),1287–1289 (2009).
- 13 Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol. Psychiatry15(1),18–22 (2010).
- 14 Keers R, Uher R. Gene–environment interaction in major depression and antidepressant treatment response. Curr. Psychiatry Rep.14(2),129–137 (2012).
- 15 Mandelli L, Marino E, Pirovano A et al. Interaction between SERTPR and stressful life events on response to antidepressant treatment. Eur. Neuropsychopharmacol.19(1),64–67 (2009).
- 16 Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Kessing LV. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment. Eur. Neuropsychopharmacol.20(5),327–335 (2010).
- 17 Keers R, Uher R, Huezo-Diaz P et al. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. Pharmacogenom. J.11(2),138–145 (2011).
- 18 Nanni V, Uher R, Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am. J. Psychiatry169(2),141–151 (2011).
- 19 Eley TC, Hudson JL, Creswall C et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol. Psychiatry17(3),236–237 (2012).